Surgery
Surgery
Surgery
QUESTIONS
B Y : D EEPANSHI MA L H OTRA
Q1. WHAT IS SHOCK?
WRITE
ETIOPATHOGENESIS AND
MANAGEMENT OF
SEPTIC SHOCK?
Shock is defined as a generalised state of low tissue perfusion which is
inadequate for normal cellular repiration, resulting in severe dysfunction of vital
organs.
TYPES OF SHOCK:
1. Hypovolemic Shock
2. Septic shock
3. Neurogenic shock
4.Cardiogenic shock
5.Anaphylactic Shock
SEPTIC SHOCK
• ETIOLOGY:
• Due to infection caused by bacteria, fungi or
protozoa.
• In most of cases it is due to gram negative
organisms including E.coli,
Kleibsella,Proteus.
• Clinically there are two types of shock;
1. Early warm shock- Toxin cause cutaneous
vasodilation and skin is warm and pink.
Diagnosis is easily made as there is associated
focus of infection in the body.
2. Late cold shock- If toxemia persists, it leads
to increased capillary permeability,
hypovolemia, decreased cardiac output,
tachycardia. Skin is cold and clammy. If toxemia
still perisists it can lead to Multiple Organ
dysfunction syndrome and multiple system
organ failure.
MANAGEMENT
• GENERAL MEASURES-
1. Establish clear airway and maintenance of adequate ventilation and oxygenation.
2. If patient is unconscious with breathing difficulty, endotracheal intubation may be required.
3. Maintenance of blood pressure-
A large bore cannula (16G) is inserted into forearm vein and Iv fluid bolus is given- 10-15ml/kg
bodyweight over 15-20mins and then reassess the patient if rcondition improved or not, may
require repeat bolus.
Maintenance fluid- 4ml/kg/hr for first 10kg
2ml/kg/hr for next kg
1ml/kg from 21kgs onwards
• Consider use of inotropes only after sufficient bolus
fluids.
• SPECIFIC TREATEMENT-
• Treat infection by-
• Broad spectrum antibiotics
• Wound debridement, Abscess drainage
• Treat shock by-
• IV fluid infusion
• Vasopressor drugs(noradrenaline)
• Steroids in high dose after 4 hours to improve
the cardiac, renal and pulmonary functions of body.
AXILLARY ABSCESS IN SEPTIC
SHOCK PATIENT
Q2.
MALIGNANT
MELANOMA
MALIGNANT MELANOMA
• It is a malignant tumout arising from melanocytes.
• Most commonly seen in young adults.
• It has high chances of metastasis and most likely to cause cancer related death.
• Origin - It may arise denovo in normal skin or malignant change may occur in pre
existing mole(most common- Junctional and Compound nevus)
• Common site- Back, Arms,Neck, Scalp
• Spread-
Local extension
Lymphatic spread- It occurs to regional lymph nodes by embolization.
MALIGNANT MELANOMA
3. genetic
Predisposing factors: 1. white race 2. ultraviolet rays 4. trauma
predisposition
1. Pigmented skin
2. Variable size and 3. Surface may be flat
Clinical features- lesion, usually black in 4. firm in consistency
margins are irregular or raised
color
5. mobility- tumour
arises from skin and
can be lifted from
deeper structures.
CLASSIFICATION
STAGING
• Clinical staging-
Stage1- Primary tumour only
Stage2- Enlargement of regional lymph nodes
Stage3- Distant metastasis
•Treatement-
Surgical excision is the treatement of choice. It is resistent to both Rt and CT. 1-2cm of healthy
margin should be excised. Excision elliptical along Langer line to allow tension free closure.
If lymph nodes 1. aim of
are involved, Stage 3 treatement is
block dissection. palliative only
Q3. BASAL
CELL
CARCINOMA
BCC
Tubercular ulcer
Syphilitic ulcer
Keratoacanthoma.
TREATMENT
• Treatment of primary lesion:
• Surgery and radiotherapy are equally effective. Principles of local treatment are same
as for basal cell carcinoma
• Tumor should be excised with a healthy margin. A4mm clearance margin should be
achieved <2cm and 1cm clearance if >2cm tumor.
• Treatment of metastatic lymph nodes:
• The regional lymph node enlargement can be due to secondary infection of the
ulcerated growth. In such case, the decision for surgery should be taken only if lymph
nodes do not regress with antibiotic treatment. Diagnosis of metastatic deposits in
lymph nodes is confirmed by fine needle aspiration biopsy (FNAB). . The treatment is
block dissection of regional lymph nodes.
Q5. ENUMERATE
SKIN
MALIGNANCIES
• Basal cell carcinoma
• Squamous cell carcinoma
• Malignant melanoma
• Merkel cell carcinoma
H
Q6. WAYS OF SPREAD OF
MALIGNANT DISEASE WITH AT
LEAST ONE EXAMLE OF EACH
SPREAD OF MALIGNANT DISEASES
• One of the cardinal features of malignant tumors is the ability to invade and destroy
adjoining structures (local invasion or direct spread) and disseminate to distant sites.
• Routes of Metastasis
• 1.Lymphatic spread
• 2. Haematogenous spread
3.Spread along body cavities and natural passages (Trans coelomic spread, along
epithelium-lined surfaces. spread via csf, implantation)
• 1. LYMPHATIC SPREAD
• In general, carcinomas metastasise by lymphatic route while
sarcomas favour haematogenous route. However, some sarcomas may also spread by
lymphatic pathway.
• The involvement of lymph nodes by malignant cells may be of two forms:
• i) Lymphatic permeation
• . ii) Lymphatic emboli
I